Consegna (pronounced: con – sen – ya) is committed to identifying and purchasing break-through therapeutic drug delivery technologies that not only have significant potential for success in the global medical market, but also are targeted to bring our shareholders return on their initial investment.
Consegna’s goal is to increase this investment in the medium to long term through purchasing therapeutic drug delivery products and technologies that are in the mid to late stage of their development. Consegna then navigates them through the testing, design and further development phases of their growth to prepare them for licensing to a large pharmaceutical organisation with considerable knowledge and experience in the space.